• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
GTG
Click for more information
0.00% 3.9¢

GENETIC TECHNOLOGIES LIMITED - Announcements

Market Cap $5.671M  ! watchlist Created with Sketch. Add to my watchlist

Genetic Technologies Limited is an Australia-based diversified molecular diagnostics... Genetic Technologies Limited is an Australia-based diversified molecular diagnostics company. The Company is engaged in providing genomics-based tests on health, wellness and serious disease through its geneType and EasyDNA brands. The Company offers cancer predictive testing and assessment tools to help physicians to improve health outcomes for people around the world. The Company has a proprietary risk stratification platform that integrates clinical and genetic risk to deliver outcomes to physicians and individuals. The Company operates through three segments: EasyDNA, AffinityDNA, and GeneType / Corporate. EasyDNA segment relates to EasyDNA branded test sales and expenses. AffinityDNA segment relates to AffinityDNA branded test sales and expenses. GeneType / Corporate segment relates to geneType branded test sales and expenses, including corporate charges. The GeneType test is for breast cancer, colorectal cancer, ovarian cancer, prostate cancer, coronary artery disease and morMore

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
GTG China AnnouncementPRICE SENSITIVE27/03/19
GTG Trading HaltPRICE SENSITIVE27/03/19
GTG Pause in TradingPRICE SENSITIVE27/03/19
GTG Investor Presentation 19 March 2019PRICE SENSITIVE20/03/19
GTG Lapse of Employee Share Options12/03/19
GTG Half Yearly Report and AccountsPRICE SENSITIVE27/02/19
GTG ASX Lodgement Supplementary ProspectusPRICE SENSITIVE18/02/19
GTG GTG US and UK Research CollaborationPRICE SENSITIVE01/02/19
GTG Quarterly Update and 4CPRICE SENSITIVE30/01/19
GTG GTG receives Nasdaq Deficiency Notice29/01/19
GTG End of Year R&D UpdatePRICE SENSITIVE21/12/18
GTG Blockshine Health ASX AnnouncementPRICE SENSITIVE21/12/18
GTG Appendix 3B13/12/18
GTG Appointment of COO, CFO & Company Secretary11/12/18
GTG Results from 2018 Annual General Meeting29/11/18
GTG 2018 Annual General Meeting materialsPRICE SENSITIVE29/11/18
GTG Change to CFO & Company Secretary21/11/18
GTG Lodgement Prospectus and Appendix 3BPRICE SENSITIVE19/11/18
GTG Change to CEO's Remuneration08/11/18
GTG US Annual Report on Form 20-F01/11/18
GTG Quarterly Activities Report & Appendix 4C - 30 Sept. 2018PRICE SENSITIVE30/10/18
GTG Notice of 2018 Annual General Meeting/Proxy Form30/10/18
GTG Appendix 3B25/10/18
GTG Investor Presentation October 201823/10/18
GTG Lapse of Employee Share Options15/10/18
GTG GTG Invited to Establish Market Presence in Hainan, ChinaPRICE SENSITIVE17/09/18
GTG Appendix 4G & Corporate Governance Statement 30 June 201830/08/18
GTG Appendix 4E and Financial Report 2018PRICE SENSITIVE30/08/18
GTG Hainan Invitation to discuss Market Entry into ChinaPRICE SENSITIVE21/08/18
GTG Proposed JV with Beijing Zishan Health Consultancy LimitedPRICE SENSITIVE16/08/18
GTG Lodgement of Prospectus and Appendix 3BPRICE SENSITIVE08/08/18
GTG Genetic Technologies Secures A$20M Equity Placement FacilityPRICE SENSITIVE08/08/18
GTG Swisstec UpdatePRICE SENSITIVE07/08/18
GTG Formalisation of Strategic Alliance with Blockchain GlobalPRICE SENSITIVE02/08/18
GTG Quarterly Activities Report & Appendix 4C - 30 June 2018PRICE SENSITIVE31/07/18
GTG Appointment of Swisstec as Non-Exclusive Asian Distributor30/07/18
GTG Ceasing to be a substantial holder20/07/18 download Created with Sketch. 169.77KB
GTG Expansion of Genetic Risk Assessment TestsPRICE SENSITIVE16/07/18 download Created with Sketch. 423.46KB
GTG Change in substantial holding13/07/18 download Created with Sketch. 208.03KB
GTG Lapse of Employee Share Options29/06/18 download Created with Sketch. 691.55KB
GTG Swisstec Heads of AgreementPRICE SENSITIVE19/06/18 download Created with Sketch. 613.77KB
GTG Binding Project Shivom AgreementPRICE SENSITIVE07/06/18 download Created with Sketch. 442.28KB
GTG NHMRC Partnership Grant AwardedPRICE SENSITIVE01/05/18
GTG Quarterly Activities Report & Appendix 4C - 31 March 2018PRICE SENSITIVE30/04/18
GTG Research Agreement - Enhancement of Breast Cancer Risk TestPRICE SENSITIVE16/03/18
GTG Project Shivom Strategic AlliancePRICE SENSITIVE06/03/18
GTG Appendix 4D & Half Year Financial Report - 31 December 2017PRICE SENSITIVE27/02/18
GTG Reinstatement to Official QuotationPRICE SENSITIVE15/02/18
GTG Strategic Alliance and Capital RaisingPRICE SENSITIVE15/02/18
GTG Update on Strategic Alliance12/02/18
GTG Change of Chief Executive OfficerPRICE SENSITIVE06/02/18
GTG Appendix 3X - Peter Rubenstein05/02/18
GTG Appendix 3X - Samuel Lee05/02/18
GTG Appendix 3X - Jerzy Muchnicki05/02/18
GTG Appointment of Chairman05/02/18
GTG Appendix 3Z - Eutillio Buccili and Grahame Leonard02/02/18
GTG Voluntary Suspension from Official QuotationPRICE SENSITIVE31/01/18
GTG Results from 31 January 2018 General MeetingPRICE SENSITIVE31/01/18
GTG Resignation of Directors30/01/18
GTG Trading HaltPRICE SENSITIVE30/01/18
GTG Quarterly Activities Report & Appendix 4C - 31 December 2017PRICE SENSITIVE29/01/18
GTG Nasdaq Listing Compliance Regained09/01/18
GTG Response to ASX Price QueryPRICE SENSITIVE21/12/17
GTG Notice of General Meeting and Sample Proxy20/12/17
GTG Update on Strategic Review InitiativePRICE SENSITIVE12/12/17
GTG Becoming a substantial holder04/12/17
GTG Notice Received Under Section 249D of the Corporations Act01/12/17
GTG Results from the 2017 Annual General Meeting23/11/17
GTG 2017 Annual General Meeting Presentation23/11/17
GTG Quarterly Activities Report - 30 September 2017PRICE SENSITIVE30/10/17
GTG Annual Report 201723/10/17
GTG Notice of 2017 Annual General Meeting23/10/17
GTG Transition to Online Commercial Platform for BREVAGenplusPRICE SENSITIVE21/09/17
GTG Appendix 4G and Corporate Governance Statement 201729/08/17
GTG Appendix 4E and Financial Report 2017PRICE SENSITIVE29/08/17
GTG Comprehensive Review of Strategic AlternativesPRICE SENSITIVE25/08/17
GTG Breast Cancer Awareness Month Promotion for BREVAGenplusPRICE SENSITIVE01/08/17
GTG Quarterly Activities Report & Appendix 4C - 30 June 2017PRICE SENSITIVE27/07/17
GTG Nasdaq Deficiency NoticePRICE SENSITIVE21/07/17
GTG Appendix 3Y25/05/17
GTG Quarterly Activities Report & Appendix 4C - 31 March 2017PRICE SENSITIVE27/04/17
GTG Change in Pricing and Billing ProgramPRICE SENSITIVE31/03/17
GTG Partnership to Promote BREVAGenplus, Second YearPRICE SENSITIVE29/03/17
GTG Appendix 4D and 31 December 2016 Half Year Financial ReportPRICE SENSITIVE23/02/17
GTG Employee Share Options Issued & Forfeited20/02/17
GTG Quarterly Activities Report & Appendix 4C - 31 December 2016PRICE SENSITIVE27/01/17
GTG Cleansing Notice06/12/16
GTG Capital Raising Update & Appendix 3B06/12/16
GTG AUD 8.1 Million Capital RaisingPRICE SENSITIVE02/12/16
GTG License Agreement to Develop Colorectal Cancer Risk TestPRICE SENSITIVE29/11/16
GTG 2016 Annual General Meeting Results23/11/16
GTG 2016 Annual General Meeting Presentation23/11/16
GTG Quarterly Activities Report & Appendix 4C, 30 September 2016-GTG.AX PRICE SENSITIVE27/10/16
GTG Annual Report 2016-GTG.AX 24/10/16
GTG Notice of 2016 Annual General Meeting-GTG.AX 24/10/16
GTG Dallas Race for the Cure event promotion-GTG.AX 03/10/16
GTG Appendix 4G & Corporate Governance Statement 2016-GTG.AX 29/08/16
GTG Appendix 4E & Financial Report 2016-GTG.AX PRICE SENSITIVE29/08/16
GTG Quarterly Activities Report & Appendix 4C - 30 June 2016-GTG.AX PRICE SENSITIVE28/07/16
GTG Genetic Technologies and Verizon IndyCar Series Driver Pippa-GTG.AX 22/06/16
GTG China Announcement
27/03/19PRICE SENSITIVE
GTG Trading Halt
27/03/19PRICE SENSITIVE
GTG Pause in Trading
27/03/19PRICE SENSITIVE
GTG Investor Presentation 19 March 2019
20/03/19PRICE SENSITIVE
GTG Lapse of Employee Share Options
12/03/19
GTG Half Yearly Report and Accounts
27/02/19PRICE SENSITIVE
GTG ASX Lodgement Supplementary Prospectus
18/02/19PRICE SENSITIVE
GTG GTG US and UK Research Collaboration
01/02/19PRICE SENSITIVE
GTG Quarterly Update and 4C
30/01/19PRICE SENSITIVE
GTG GTG receives Nasdaq Deficiency Notice
29/01/19
GTG End of Year R&D Update
21/12/18PRICE SENSITIVE
GTG Blockshine Health ASX Announcement
21/12/18PRICE SENSITIVE
GTG Appendix 3B
13/12/18
GTG Appointment of COO, CFO & Company Secretary
11/12/18
GTG Results from 2018 Annual General Meeting
29/11/18
GTG 2018 Annual General Meeting materials
29/11/18PRICE SENSITIVE
GTG Change to CFO & Company Secretary
21/11/18
GTG Lodgement Prospectus and Appendix 3B
19/11/18PRICE SENSITIVE
GTG Change to CEO's Remuneration
08/11/18
GTG US Annual Report on Form 20-F
01/11/18
GTG Quarterly Activities Report & Appendix 4C - 30 Sept. 2018
30/10/18PRICE SENSITIVE
GTG Notice of 2018 Annual General Meeting/Proxy Form
30/10/18
GTG Appendix 3B
25/10/18
GTG Investor Presentation October 2018
23/10/18
GTG Lapse of Employee Share Options
15/10/18
GTG GTG Invited to Establish Market Presence in Hainan, China
17/09/18PRICE SENSITIVE
GTG Appendix 4G & Corporate Governance Statement 30 June 2018
30/08/18
GTG Appendix 4E and Financial Report 2018
30/08/18PRICE SENSITIVE
GTG Hainan Invitation to discuss Market Entry into China
21/08/18PRICE SENSITIVE
GTG Proposed JV with Beijing Zishan Health Consultancy Limited
16/08/18PRICE SENSITIVE
GTG Lodgement of Prospectus and Appendix 3B
08/08/18PRICE SENSITIVE
GTG Genetic Technologies Secures A$20M Equity Placement Facility
08/08/18PRICE SENSITIVE
GTG Swisstec Update
07/08/18PRICE SENSITIVE
GTG Formalisation of Strategic Alliance with Blockchain Global
02/08/18PRICE SENSITIVE
GTG Quarterly Activities Report & Appendix 4C - 30 June 2018
31/07/18PRICE SENSITIVE
GTG Appointment of Swisstec as Non-Exclusive Asian Distributor
30/07/18
GTG Ceasing to be a substantial holder
20/07/18 download Created with Sketch. 169.77KB
GTG Expansion of Genetic Risk Assessment Tests
16/07/18PRICE SENSITIVE download Created with Sketch. 423.46KB
GTG Change in substantial holding
13/07/18 download Created with Sketch. 208.03KB
GTG Lapse of Employee Share Options
29/06/18 download Created with Sketch. 691.55KB
GTG Swisstec Heads of Agreement
19/06/18PRICE SENSITIVE download Created with Sketch. 613.77KB
GTG Binding Project Shivom Agreement
07/06/18PRICE SENSITIVE download Created with Sketch. 442.28KB
GTG NHMRC Partnership Grant Awarded
01/05/18PRICE SENSITIVE
GTG Quarterly Activities Report & Appendix 4C - 31 March 2018
30/04/18PRICE SENSITIVE
GTG Research Agreement - Enhancement of Breast Cancer Risk Test
16/03/18PRICE SENSITIVE
GTG Project Shivom Strategic Alliance
06/03/18PRICE SENSITIVE
GTG Appendix 4D & Half Year Financial Report - 31 December 2017
27/02/18PRICE SENSITIVE
GTG Reinstatement to Official Quotation
15/02/18PRICE SENSITIVE
GTG Strategic Alliance and Capital Raising
15/02/18PRICE SENSITIVE
GTG Update on Strategic Alliance
12/02/18
GTG Change of Chief Executive Officer
06/02/18PRICE SENSITIVE
GTG Appendix 3X - Peter Rubenstein
05/02/18
GTG Appendix 3X - Samuel Lee
05/02/18
GTG Appendix 3X - Jerzy Muchnicki
05/02/18
GTG Appointment of Chairman
05/02/18
GTG Appendix 3Z - Eutillio Buccili and Grahame Leonard
02/02/18
GTG Voluntary Suspension from Official Quotation
31/01/18PRICE SENSITIVE
GTG Results from 31 January 2018 General Meeting
31/01/18PRICE SENSITIVE
GTG Resignation of Directors
30/01/18
GTG Trading Halt
30/01/18PRICE SENSITIVE
GTG Quarterly Activities Report & Appendix 4C - 31 December 2017
29/01/18PRICE SENSITIVE
GTG Nasdaq Listing Compliance Regained
09/01/18
GTG Response to ASX Price Query
21/12/17PRICE SENSITIVE
GTG Notice of General Meeting and Sample Proxy
20/12/17
GTG Update on Strategic Review Initiative
12/12/17PRICE SENSITIVE
GTG Becoming a substantial holder
04/12/17
GTG Notice Received Under Section 249D of the Corporations Act
01/12/17
GTG Results from the 2017 Annual General Meeting
23/11/17
GTG 2017 Annual General Meeting Presentation
23/11/17
GTG Quarterly Activities Report - 30 September 2017
30/10/17PRICE SENSITIVE
GTG Annual Report 2017
23/10/17
GTG Notice of 2017 Annual General Meeting
23/10/17
GTG Transition to Online Commercial Platform for BREVAGenplus
21/09/17PRICE SENSITIVE
GTG Appendix 4G and Corporate Governance Statement 2017
29/08/17
GTG Appendix 4E and Financial Report 2017
29/08/17PRICE SENSITIVE
GTG Comprehensive Review of Strategic Alternatives
25/08/17PRICE SENSITIVE
GTG Breast Cancer Awareness Month Promotion for BREVAGenplus
01/08/17PRICE SENSITIVE
GTG Quarterly Activities Report & Appendix 4C - 30 June 2017
27/07/17PRICE SENSITIVE
GTG Nasdaq Deficiency Notice
21/07/17PRICE SENSITIVE
GTG Appendix 3Y
25/05/17
GTG Quarterly Activities Report & Appendix 4C - 31 March 2017
27/04/17PRICE SENSITIVE
GTG Change in Pricing and Billing Program
31/03/17PRICE SENSITIVE
GTG Partnership to Promote BREVAGenplus, Second Year
29/03/17PRICE SENSITIVE
GTG Appendix 4D and 31 December 2016 Half Year Financial Report
23/02/17PRICE SENSITIVE
GTG Employee Share Options Issued & Forfeited
20/02/17
GTG Quarterly Activities Report & Appendix 4C - 31 December 2016
27/01/17PRICE SENSITIVE
GTG Cleansing Notice
06/12/16
GTG Capital Raising Update & Appendix 3B
06/12/16
GTG AUD 8.1 Million Capital Raising
02/12/16PRICE SENSITIVE
GTG License Agreement to Develop Colorectal Cancer Risk Test
29/11/16PRICE SENSITIVE
GTG 2016 Annual General Meeting Results
23/11/16
GTG 2016 Annual General Meeting Presentation
23/11/16
GTG Quarterly Activities Report & Appendix 4C, 30 September 2016-GTG.AX
27/10/16PRICE SENSITIVE
GTG Annual Report 2016-GTG.AX
24/10/16
GTG Notice of 2016 Annual General Meeting-GTG.AX
24/10/16
GTG Dallas Race for the Cure event promotion-GTG.AX
03/10/16
GTG Appendix 4G & Corporate Governance Statement 2016-GTG.AX
29/08/16
GTG Appendix 4E & Financial Report 2016-GTG.AX
29/08/16PRICE SENSITIVE
GTG Quarterly Activities Report & Appendix 4C - 30 June 2016-GTG.AX
28/07/16PRICE SENSITIVE
GTG Genetic Technologies and Verizon IndyCar Series Driver Pippa-GTG.AX
22/06/16
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
3.9¢ 		Change
0.000(0.00%) 		Mkt cap ! $5.671M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0
GTG (ASX) Chart

Top Stories

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
Quit before you're fired: Russia bans uranium exports to USA, duplicating extant US ban Russia's ban of uranium exports to the USA came days before Biden allowed Ukraine use long-range missiles.
US election outcomes: Key economic and market takeaways This week on Money @ Investing, Mitch Olarenshaw and I break down the recent U.S. presidential election, focusing on its effects on the stock market and the broader economic outlook. Here’s what we covered:1. Election results and policy insightsThe Republican Party&CloseCurlyQuote...
Power gets set for 1000-metre maiden drilling program in Brazil Power Minerals Ltd is planning a maiden drilling program to 1000 metres to test targets at its Nióbio project in Brazil
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.